GlassScriptPhysician profile
Andrew J Powers
NPI 1619363249
$3,317.41
in general payments reported to CMS, 2019-2025
11 companies · $16.14 in 2025
The $16.14 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.23 · 2021: $3,081 · 2022: $26.00 · 2024: $151 · 2025: $16.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,032.26 | 2021 | |
| Medtronic, INC. | $65.04 | 2024 | Closurefast |
| Smith+Nephew, INC. | $53.95 | 2024 | Pico |
| Medtronic Vascular, INC. | $43.23 | 2019 | |
| Ethicon US, LLC | $28.28 | 2024 | Echelon; Endopath, Vistaseal, Echelon Endopath |
| Depuy Synthes Sales INC. | $26.00 | 2022 | |
| Baudax Bio INC. | $19.39 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.08 | 2021 | |
| Conmed Corporation | $16.14 | 2025 | Airseal |
| Baxter Healthcare | $11.12 | 2021 | |
| Merit Medical Systems INC | $3.92 | 2024 | Elation Balloon Dilator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.